The role of N-acetyl-methioninate as a new stabilizer for albumin products
Sodium octanoate (Oct) and N-acetyl- l-tryptophanate ( N-AcTrp) are widely used as stabilizers during the pasteurization of albumin products. However, N-AcTrp has a possible side effect of intracerebral disease. To provide safe and risk-free albumin products, we validated N-acetyl-methioninate ( N-A...
Saved in:
Published in | International journal of pharmaceutics Vol. 329; no. 1; pp. 19 - 24 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
01.02.2007
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Sodium octanoate (Oct) and
N-acetyl-
l-tryptophanate (
N-AcTrp) are widely used as stabilizers during the pasteurization of albumin products. However,
N-AcTrp has a possible side effect of intracerebral disease. To provide safe and risk-free albumin products, we validated
N-acetyl-methioninate (
N-AcMet) as a new stabilizer for albumin products. The effect of
N-AcMet on oxidation was examined using 2,2′-azobis(2-amidino-propane) dihydrochloride (AAPH) as an oxidizing agent. Carbonyl content in the presence of
N-AcMet, as well as that in the presence of
N-AcTrp after 24
h (
Anraku et al., 2004), was significantly decreased. The effect of AAPH on the oxidative status of 34-Cys on human serum albumin was also studied by HPLC. It was found that
N-AcMet as well as
N-AcTrp, has a large protective effect on the sulfhydryl group after 1
h. Further,
N-AcMet was found to be a superior radical scavenger to
N-AcTrp using 1,1′-diphenyl-2-picrylhydrazyl (DPPH) radicals. The thermal stabilizing role of
N-AcMet manifested as an increase in denaturation temperature and calorimetric enthalpy, as determined by differential scanning calorimetry (DSC). In the present study, we suggest that use of
N-AcMet in albumin preparation is safe and free of risk of side effects. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0378-5173 1873-3476 |
DOI: | 10.1016/j.ijpharm.2006.08.014 |